Fitch downgraded Franklin, Tenn.-based Community Health Systems’ credit rating to “C” from “CCC+” on Nov. 17, after the for-profit system moved to swap about $1.2 billion of junior-lien debt for new senior secured notes.
Fitch said in its Nov. 17 report that it views the deal as a distressed debt exchange. Under the agency’s criteria, that label applies when an exchange materially reduces terms for creditors and lets the issuer avoid an eventual and probable default. Once the exchange closes, Fitch expects to cut CHS to restricted default, then immediately re-rate the system and its debt based on its post-exchange credit profile.
CHS announced Nov. 9 that its subsidiary plans to exchange about $1.24 billion of 6.875% junior-priority secured notes due 2029 for new 10.25% senior secured notes due 2035. Holders of about 52% of the notes signed a support agreement to tender them and approve amendments stripping substantially all restrictive covenants from the old notes. Holders who tender by Nov. 23 receive par; those who tender later, through Dec. 10, receive $970 in new notes per $1,000 of old notes.
The swap pushes out maturities but leaves total debt unchanged. Fitch expects CHS’ EBITDA leverage, net of distributions to noncontrolling interests, to reach 8.5 times by the end of 2026, up from 7.7 times at the end of 2025. After the exchange, the nearest maturity is $600 million of first-lien notes due January 2029. In 2030, another $1.5 billion of first-lien notes and the remaining $1.2 billion of second-lien notes come due. Fitch said deleveraging “remains imperative.”
Free cash flow, which turned modestly positive in 2025 for the first time in several years, has swung negative in 2026 on revenue shortfalls and margin compression, according to Fitch. The agency projects it will near breakeven in 2027.
The expiration of enhanced ACA subsidies at the end of 2025 cut into 2026 EBITDA by more than the $20 million to $30 million CHS first expected, as uninsured volumes rose, according to the report. Stricter Medicaid eligibility enforcement, work requirements taking effect in the second half of 2027 in half the states where CHS operates and caps on certain Medicaid payments from 2028 to 2032 add more strain. Fitch said the Congress elected in early November could reverse some of those cuts, though relief is uncertain, and that funding from the Rural Health Transformation Program should provide a partial offset.
Fitch said CHS’ leverage and refinancing risk are well above those of Dallas-based Tenet Healthcare, rated “BB,” and King of Prussia, Pa.-based Universal Health Services, rated “BB+.”
CHS has offloaded 10 hospitals in 2026 as it works to reduce debt. As of Sept. 30, it operated 60 hospitals with more than 8,000 beds in 12 states. It had $900 million in liquidity at the end of the third quarter, including $745 million available under its revolver and $155 million in cash.
Fitch last downgraded CHS in December 2023, to “CCC+” from “B-.” The system faced a similar action in 2018, when Fitch cut it to “C” after it launched an exchange offer on unsecured notes.